This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biotech Stock Bubble Debate in 14 Charts

BOSTON ( TheStreet) -- Checking in on the "Biotech Bubble: Yeah or Nay?" debate:

Before we start, let's agree the biotech sector is still having an unbelievable year. IBB Chart IBB data by YCharts

But biotech stocks have underperformed the broader market in the past month. IBB Chart IBB data by YCharts

Momentum-driven biotech stocks -- mostly small- and mid-cap -- have been hit with some serious selling over the past month. These were some of the sector's highest flyers, but not lately. I'm talking about stocks like:

Celldex Therapeutics (CLDX - Get Report) : CLDX Chart CLDX data by YCharts

Clovis Oncology (CLVS): ^NBI Chart ^NBI data by YCharts

and Immunomedics (IMMU): IMMU Chart IMMU data by YCharts

2013 is shaping up to be a record year for biotech IPOs, but not all of the stellar debuts have staying power.

Bluebird Bio (BLUE - Get Report): BLUE Chart BLUE data by YCharts

Alcobra Pharma (ADHD): ADHD Chart ADHD data by YCharts

Onconova Therapeutics (ONTX - Get Report): ONTX Chart ONTX data by YCharts

Stemline Therapeutics (STML): STML Chart STML data by YCharts

Some biotech IPOs keep moving higher, like...

Receptos (RCPT) RCPT Chart RCPT data by YCharts

and Ambit BioSciences (AMBI): AMBI Chart AMBI data by YCharts

Big-cap biotech stocks are still performing strongly. Is there an investor flight to quality companies like Gilead Sciences (GILD), Amgen (AMGN), Biogen Idec (BIIB) and Celgene (CELG - Get Report)? GILD Chart GILD data by YCharts

It's definitely NOT been a hard-knock life for orphan drug stocks in 2013: AEGR Chart AEGR data by YCharts

But investors have sent orphans begging in the past month: AEGR Chart AEGR data by YCharts

-- Reported by Adam Feuerstein in Boston.

Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback; click here to send him an email.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AEGR $2.32 -2.90%
BLUE $38.69 -5.00%
CELG $101.72 0.81%
CLDX $3.50 -8.60%
ONTX $0.41 2.50%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs